Heal Capital

We are inspired by a vision for the future in which data, computing, networks, and other digital and deep technologies deliver meaningful outcomes and insight for improving health and the provision of care. We invest in both solutions intended for use in the diagnosis or cure of disease and solutions designed to help healthcare organizations - be them hospitals, biopharmas, insurers, etc. - be better at what they do. We see our sweet spot at seeding founders who are marrying in-depth understanding of the complex network of healthcare system participants with meaningful engineering innovation, advanced data science, and information technology-enabled products and services. We look for and invest in founders determined to effectively and efficiently serve these participants on the european continent, where we are based, and internationally.​ In our investment criteria and process, we are informed by a Stanford-born methodology of health technology innovation known as Biodesign. Since 2001, Biodesign has proven to de-risk the process of new venture creation by applying a need-driven and value-based approach to reinventing healthcare with the help of technology. To learn more about the methodology, head to The Student Guide to Biodesign, developed by a team of Stanford instructors and students who are passionate about education and making high-quality learning materials available and accessible to all.​ We invest in european companies as well as in selected non-european companies with ties to europe. Wherever they are, our goal is to help founders ready their companies to raise series A capital, and to access international markets. To learn more about our process, click here.

We believe that the future of modern healthcare is led by a digital revolution. Investing in solutions that help to transforms these challenges healthcare is facing. When technology is fuelled by digitalisation, innovation will thrive and grow, creating leverage for global reform. By supporting innovative digital-health startups with seed capital, extensive industry knowledge and a powerful global network, we aim to change the future of healthcare forever. Entrepreneurial capital: Our work is rooted in a deep understanding of the system in which we operate. Pioneering: We believe that the future of modern healthcare is led by a digital revolution. Committed to impact: There is an idealistic element to our proposition. The aim of our efforts is change. Human centred: People are at the core of everything we do. They are the end to our means and the why to our what. From a business perspective this translates into a strong desire to invest in a team, rather than a business plan. We believe in long term shared success. The Approach In return for the invested capital and support, Healthy.Capital acquires a minority share. We are: Team with experts Entrepreneurs by heart Specialist in building product-market fit Long term investment relationships Digital Health VC with international network Ecosystem key player Our initially invested capital ranges between EUR 200K and EUR 1 M. Once a board, and depending on the proposition, we will offer support with a startup mentality in the following areas: Strategy Building Coaching Operational Expertise Business Development Health & Care Expertise Co-investments Financial Roadmap Planning Network Expansion Healthy.Capital invests in talented founders & teams. Our focus is Digital Health Solutions Services SaaS Marketplaces Our Criteria Business entity registered in the Netherlands Company younger than 7 years old Tech component (pre-)Seed stage Excellent teams Data driven DNA Strong problem-solution fit High scalability with healthy profitability

No single company can advance healthcare alone. We accelerate access & quality across healthcare in the Philippines & beyond. Philippines-focused healthcare ventures.Build: We choose high-impact ideas, validate & build them alongside our Entrepreneurs in Residence. With our in-house expertise in launching & scaling, we provide foundational support in the early stages to set our Entrepreneurs up for success & to enable them to focus on the work that truly matters. Partner: We cooperate with companies from outside of the Philippines & within to transform healthcare, through partnerships & joint ventures. We are constantly growing our synergetic ecosystem, building on an already expansive network of health stakeholders, advisors & investors. Invest: We invest up to $250k in promising health-focused companies across stages. Our portfolio spans the entire healthcare landscape, with a special focus on consumer-centric, provider-centric& pharma-centric digital solutions.

We back outstanding entrepreneurs and their ideas with capital and Healthcare-specific expertise to create European champions. Therefore, we seek Pre-seed, Seed and Series A investment opportunities across Europe. We are a venture capital firm with deep roots at Europe’s leading tech hub Munich and a unique setup of seasoned Serial Entrepreneurs, Venture Capital Investors and Private Equity Professionals. UNIQUE SECTOR-FOCUSED VC FUND BACKING EUROPE’S HEALTH TECH DISRUPTORS We are focused on venture capital investments in Europe’s health tech challengers. We are passionate about companies that make a lasting impact on Europe’s healthcare system by boosting efficiency and transparency, make living healthy easier, and enable constant change for improved healthcare. Our deep healthcare expertise coupled with a collaborative style of developing a personal connection with each and every one of our portfolio companies allows us to accelerate growth without interfering with the entrepreneurial freedom of our founders. Get in touch with us when you’re ready to learn more; we can’t wait to meet you! The healthcare industry, one of societies most crucial ecosystems, is going through a process of change where daring tech founders of today will shape the healthcare system of tomorrow. We are convinced that the Covid-19 pandemic has triggered a wave of innovation in the Health Tech market and therefore we strive to equip founders with the right resources to reach their goal in riding the health tech wave. OUR INVESTMENT FOCUSFounding & Early Stage: We help mission driven founders to build a company at an early-stage. We support you with capital, deep healthcare and regulatory expertise, co-founder access and firm development resources starting at the (Pre)-Seed or Series A stage of your company. Growth Stage: We have the appropriate financial and firm development resources to back our early-stage founders through the extended growth stages of their companies development. Further, we engage in selective initial investments into growth stage firms. MEANING OF YZR YZR is pronounced as [ˈwaɪzər]. It is a blend of ‘wise’ and ‘Isar’ reflecting two core aspects of our values: Our investment approach is backed by unique healthcare expertise, therefore allowing us to take wise & informed investment decisions. The river ‘Isar‘ is a symbol for Munich and reflects our roots, heritage and connection with Europe’s deep tech epicenter.

We're backed by Vituity, the largest physician-owned partnership in the US, with 6K+ clinicians across 450+ practice locations serving 9M+patients annually. We invest in the best pre-seed, seed, and series A startups innovating across healthcare. We aspire to be your earliest design partner, fastest go-to-market accelerant, and most knowledgeable healthcare advisor on the cap table. We identify pressing healthcare challenges, validate new solutions, and apply our unique insights and strategic advantages to build where there are unmet market needs. We leverage over 50 years of industry expertise to offer invaluable clinician perspectives and healthcare insights. Our consultants collaborate with leading Fortune 500 companies, emerging startups, and government entities to empower them to master and disrupt the healthcare status quo.

Pureland Global Venture is a direct investment fund and part of the Pureland Group which targets impact investment deals in the medical technology sector. We are Singapore-based with a focus in APAC, India and the US. The fund deals with early-stage companies who have potential to inject value into the patient care system, save lives and reduce gaps in the supply and demand chains. Since we were established, we have invested in multiple medical sectors in both medical devices and ML-based solutions. MISSION - WHAT WE WANT TO ACHIEVE Established with the goal of giving people access to healthcare and also providing them with clinical choices, our mission is to bring medical solutions and savings to 100 million people around the world. We strongly believe in people who don’t just care about profit and who want to make the world a better place by solving real issues and pushing forward the latest evolution in medical technology. We envision bringing together impactful start-ups, commercial partners, insightful advisors and clinical providers in order to build a sustainable foundation for affordable, accessible and high-quality healthcare. WHY HEALTHCARE? Worldwide healthcare spending is expected to continue to rise at an alarming rate with a slight difference in some countries. Of all the leading factors, life expectancy appears to still be on the rise. By 2050, 1/6 people in the world will be over the age of 65 (16%), an increase from 1/11 in 2019 (9%). The number of people aged over 80 is projected to be 426 million by 2050 according to the United Nations population prospects. As we are entering a smart-health generation, the ecosystem demands more cost-effective solutions and appropriate treatments which can be delivered at the appropriate time and location. Clinicians use technology to give more holistic solutions to an aging population and provide more accurate diagnostics. Care delivery stakeholders use data and communicate more effectively and efficiently. Patients are involved in their own treatment plans and more healthcare access is delivered to people who did not previously have access. Unfortunately, we still face issues such as the increasing cost of healthcare, aging population, limited resources and shortages of healthcare professionals in various parts of the world. In order to combat these problems, government support and spending alone is not enough. We believe that these shortages can be filled by technology, which can be our solution for ensuring sufficient healthcare for future generations. This is also the reason why we are keen on enterprises which can provide solutions to combat these issues and create positive changes in the smart-health era. Founded in Singapore, we hope to be able to leverage the geographical advantage of Asia, and put together growth opportunities for these technologies which will make them accessible globally in the long term. WE SUPPORT START-UPS POST INVESTMENTFOUNDER SUPPORT: Start-ups regularly face critical decision-making as businesses grow from continuous market feedback and unexpected situations. We understand how difficult it can be and we will work together with the founders as a team in order to assist them with scaling their company, whether from networking referrals at the R&D stage, business strategy improvement at the growth stage, or EBITDA optimisation at a later stage. We offer support to founders for the optimisation of team structure as their businesses grow so they can overcome challenges and compete globally. MANUFACTURING SUPPORT: Manufacturing is one of the most crucial aspects of any device company, but it is often where mistakes are made. We advise our companies who experience manufacturing challenges from prototyping to mass production. In order to achieve this, we provide strategic value to our portfolio companies by connecting them to cost-effective manufacturing partners throughout the plastic, PCBA, silicon/rubber and final assembly industries. Our partners are high-mix and low-volume suppliers who understand the challenges of start-ups. Outside of production, we assist companies with lower case costing, set-up and management. GOVERNANCE: Establishing a good corporate culture and necessary internal control will mitigate business losses from major risks and lay the foundations for a company to improve. In a later stage funding cycle, correct corporate governance and internal control are paramount before larger funds buy into the company’s vision and growth story. We have a complete understanding of control and our networks are comprised of global experts in financial knowledge and risk assurance who can work together with our companies. FUNDRAISING: We typically fund companies while they are still young, from their seed to their series A round. Given the heavy research and development nature of medical technology companies, they usually require additional funding in order to boost their business quickly. Post-investment, we will not only collaborate on budgets and milestone adjustments but will more importantly offer assistance with financial modeling and revenue projection. This ensures that companies gain a higher chance of future investment. Finally, we work with other larger funds all over the world who specialise in revenue growth in order to understand their needs when they select their investment targets. EXIT: We seek founders with longer-term goals and a desire to take their companies to global players. Given our evergreen nature and flexible exit strategy, we are well suited to the long operation cycle of healthcare companies. At the same time, we understand and respect that some founders have a shorter term goal of M&A to boost market shares, expand business services or leverage bigger players to scale the company. We are experienced in company buy-out considerations and offer our support to founders as long as the company fits within our investment mandate.